Publications

Publications

  1. Sharma, A, Alatise, OI, Adisa, AO, Arowolo, OA, Olasehinde, O, Famurewa, OC et al.. Treatment of colorectal cancer in Sub-Saharan Africa: Results from a prospective Nigerian hospital registry. J Surg Oncol. 2019; :. doi: 10.1002/jso.25768. PubMed PMID:31742699 .
  2. Nierop, PMH, Höppener, DJ, van der Stok, EP, Galjart, B, Buisman, FE, Balachandran, VP et al.. Histopathological growth patterns and positive margins after resection of colorectal liver metastases. HPB (Oxford). 2019; :. doi: 10.1016/j.hpb.2019.10.015. PubMed PMID:31735649 .
  3. Datta, J, Smith, JJ, Chatila, WK, McAuliffe, JC, Kandoth, C, Vakiani, E et al.. Co-Altered Ras/B-raf and TP53 is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Metastatic Colorectal Cancer Patients. Clin. Cancer Res. 2019; :. doi: 10.1158/1078-0432.CCR-19-2390. PubMed PMID:31719050 .
  4. Cercek, A, Boerner, T, Tan, BR, Chou, JF, Gönen, M, Boucher, TM et al.. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. JAMA Oncol. 2019; :. doi: 10.1001/jamaoncol.2019.3718. PubMed PMID:31670750 PubMed Central PMC6824231.
  5. Buisman, FE, Grünhagen, DJ, Homs, MYV, Grootscholten, C, Filipe, WF, Kemeny, NE et al.. Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands. Ann. Surg. Oncol. 2019;26 (13):4599-4607. doi: 10.1245/s10434-019-07973-w. PubMed PMID:31641947 .
  6. Knapp, GC, Tansley, G, Olasehinde, O, Alatise, OI, Wuraola, F, Olawole, MO et al.. Mapping Geospatial Access to Comprehensive Cancer Care in Nigeria. J Glob Oncol. 2019;5 :1-8. doi: 10.1200/JGO.19.00283. PubMed PMID:31634049 .
  7. Narayan, RR, Harris, JW, Chou, JF, Gönen, M, Bao, F, Shia, J et al.. Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases. Ann. Surg. Oncol. 2019; :. doi: 10.1245/s10434-019-07934-3. PubMed PMID:31617122 .
  8. Gamboa, AC, Aveson, VG, Zaidi, MY, Lee, RM, Jarnagin, WR, Allen, PJ et al.. Lending a hand for laparoscopic distal pancreatectomy: the optimal approach?. HPB (Oxford). 2019; :. doi: 10.1016/j.hpb.2019.09.007. PubMed PMID:31601508 .
  9. Huang, YH, Hu, J, Chen, F, Lecomte, N, Basnet, H, David, CJ et al.. ID1 mediates escape from TGF-β tumor suppression in pancreatic cancer. Cancer Discov. 2019; :. doi: 10.1158/2159-8290.CD-19-0529. PubMed PMID:31582374 .
  10. Pulvirenti, A, Javed, AA, Landoni, L, Jamieson, NB, Chou, JF, Miotto, M et al.. Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors. Ann. Surg. 2019; :. doi: 10.1097/SLA.0000000000003579. PubMed PMID:31567347 .
  11. Velayati, S, Erinjeri, JP, Brody, LA, Ziv, E, Boas, FE, Brown, KT et al.. Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver. Sarcoma. 2019;2019 :3060658. doi: 10.1155/2019/3060658. PubMed PMID:31565028 PubMed Central PMC6745165.
  12. Smith, JJ, Chatila, WK, Sanchez-Vega, F, Datta, J, Connell, LC, Szeglin, BC et al.. Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion. Cancer Med. 2019;8 (15):6538-6548. doi: 10.1002/cam4.2415. PubMed PMID:31503397 PubMed Central PMC6825986.
  13. Ntiamoah, P, Monu, NR, Abdulkareem, FB, Adeniji, KA, Obafunwa, JO, Komolafe, AO et al.. Pathology Services in Nigeria: Cross-Sectional Survey Results From Three Cancer Consortia. J Glob Oncol. 2019;5 :1-9. doi: 10.1200/JGO.19.00138. PubMed PMID:31479341 PubMed Central PMC6733183.
  14. Ayabe, RI, Narayan, RR, Ruff, SM, Wach, MM, Lo, W, Nierop, PMH et al.. Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study. HPB (Oxford). 2019; :. doi: 10.1016/j.hpb.2019.07.002. PubMed PMID:31447392 .
  15. Buisman, FE, Galjart, B, van der Stok, EP, Balachandran, VP, Boerner, T, Drebin, JA et al.. Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy. World J Surg. 2019; :. doi: 10.1007/s00268-019-05121-9. PubMed PMID:31410513 .
  16. Knapp, GC, Sharma, A, Olopade, B, Alatise, OI, Olasehinde, O, Arije, OO et al.. An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria. World J Surg. 2019;43 (11):2674-2680. doi: 10.1007/s00268-019-05100-0. PubMed PMID:31407091 .
  17. Yamashita, R, Perrin, T, Chakraborty, J, Chou, JF, Horvat, N, Koszalka, MA et al.. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation. Eur Radiol. 2019; :. doi: 10.1007/s00330-019-06381-8. PubMed PMID:31392481 .
  18. Saldia, A, Olson, SH, Nunes, P, Liang, X, Samson, ML, Salo-Mullen, E et al.. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in and . Cancer Prev Res (Phila). 2019;12 (9):599-608. doi: 10.1158/1940-6207.CAPR-18-0272. PubMed PMID:31337648 PubMed Central PMC6726560.
  19. Khalil, DN, Suek, N, Campesato, LF, Budhu, S, Redmond, D, Samstein, RM et al.. In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors. J. Clin. Invest. 2019;129 (8):3435-3447. doi: 10.1172/JCI128562. PubMed PMID:31329159 PubMed Central PMC6668692.
  20. Springer, S, Masica, DL, Dal Molin, M, Douville, C, Thoburn, CJ, Afsari, B et al.. A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med. 2019;11 (501):. doi: 10.1126/scitranslmed.aav4772. PubMed PMID:31316009 .
Search PubMed